D-Zime Ceftazidime Sodium Injection 250mg represents a high-quality sterile antibiotic formulation manufactured under strict aseptic conditions to ensure purity, potency, and thera...

D-Zime Ceftazidime Sodium Injection 250mg represents a high-quality sterile antibiotic formulation manufactured under strict aseptic conditions to ensure purity, potency, and therapeutic safety. Each vial contains Ceftazidime Sodium IP equivalent to 250mg anhydrous Ceftazidime in sterile dry powder form, designed for reconstitution with water for injection before IV or IM administration. As a third-generation cephalosporin antibiotic, it delivers broad-spectrum activity against resistant Gram-negative and select Gram-positive bacteria, providing medical professionals with a reliable treatment option for severe infections where other antibiotics may prove ineffective. The product maintains stability throughout its shelf life while ensuring consistent antibacterial performance in clinical applications.

This injection finds extensive application across hospitals, critical care units, surgical centers, and clinical institutions for treating serious bacterial infections. Medical facilities utilize it as a primary antibiotic for conditions including pneumonia, septicemia, urinary tract infections, and skin or soft tissue infections. The product demonstrates particular value in intensive care units and for immunocompromised patients, including those undergoing cancer treatment or with neutropenia. Distributors supply D-Zime to healthcare facilities seeking quality-assured antibiotics that meet rigorous medical standards, with usage spanning both public health systems and private healthcare networks worldwide to support comprehensive infection management protocols.

Healthcare providers benefit from D-Zime's consistent quality, regulatory compliance, and reliable supply chain management. The product's proven effectiveness contributes to reduced treatment durations, supporting better patient outcomes and enhancing healthcare facility reputations for infection control. Its reliability minimizes risks associated with substandard antibiotics, building trust and fostering long-term partnerships between suppliers and medical institutions. With unwavering focus on sterility and potency assurance, D-Zime stands as a preferred choice for professionals seeking effective infection management solutions that deliver measurable clinical results and operational confidence.

Key Features:
- Each vial contains Ceftazidime Sodium IP equivalent to 250mg anhydrous Ceftazidime
- Sterile dry powder formulation ensures extended shelf life and straightforward reconstitution
- Manufactured under strict aseptic conditions guaranteeing high purity and safety standards
- Broad-spectrum antibacterial activity against Gram-negative and Gram-positive bacteria
- Consistent quality and potency maintained through rigorous manufacturing protocols

Benefits:
- Provides reliable treatment for severe bacterial infections where other antibiotics fail
- Ensures patient safety through sterile manufacturing and quality control processes
- Offers broad-spectrum coverage against resistant Gram-negative and select Gram-positive bacteria
- Supports healthcare facilities in achieving improved patient outcomes and infection control
- Delivers consistent therapeutic performance and clinical reliability for medical professionals